The reality of drug pricing
By Andrew Willis | 01/03/19
High drug prices have been making headlines recently, with a recent U.S. Senate hearing into the matter earlier this week.
Should investors inject their portfolios with some pharma exposure to get behind this trend? Or are there dangerous side-effects to watch out for when getting behind companies selling thousand-dollar doses?
Harvest Portfolios Group Inc. (“Harvest”) declares the monthly cash distribution payable for Big Pharma Split Corp. of…
Harvest Portfolios Group Inc. (“Harvest”) announces the following distributions for Harvest ETFs…
Harvest ETFs Portfolio Manager Mike Dragosits explores peak interest rates, the relationship between AI and data center demand, and the…
A resurgent US manufacturing space could bolster industrial equities like those in the Harvest Industrial Leaders Income ETF (HIND:TSX).
The Harvest Equal Weight Global Utilities Income ETF (HUTL:TSX) has delivered performance and offers exposure to the AI/data center boom.
Professor and author Jeremy Siegel provides his long-term view of stocks and looks at how the upcoming US election could impact the market.